AKAnita Koroknai

Anita Koroknai

*This is an algorithmically generated author record based on publicly available information.

Anita Koroknai has a total of 20 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Hungary as a source of West Nile virus diversity and spread in Europe: insights from the 2024 transmission season

    by Anna Nagy, Károly Erdélyi, Zsuzsanna Molnár, Renáta Bagóné Lőrincz, Orsolya Nagy, Anita Koroknai, Nikolett Csonka, Kata Kerényi, Petra Forgách, Enikő Horváth, et al.

    BACKGROUND: West Nile virus (WNV) has become established across Europe, with Hungary serving as a key transmission hub since 2004. Following reduced activity during 2020–22, the 2024 season marked a resurgence with the largest geographical distribution ever recorded in Europe. AIM: To analyse the 2024 WNV transmission season in Hungary using a One Health approach and characterise circulating strains within the European phylogeographic context using comprehensive genomic surveillance. METHODS: Complete and near-complete genome sequencing was performed on 55 specimens from 38 humans, 15 birds and two Culex pipiens mosquito pools using amplicon-based next-generation sequencing. Phylogeographic analysis incorporated 637 European WNV genome sequences (2004–24) with time-scaled Bayesian phylogenetic reconstruction and continuous spatial diffusion modelling. RESULTS: Hungary reported 113 human WNV cases in 2024 (n = 111 autochthonous, 2 imported), a 3.7-fold increase from 2023 (incidence: 1.16 vs 0.31 per 100,000 population). Neuroinvasive disease predominated (92%, n = 104) with a 7.9% case fatality rate. All 55 sequenced strains belonged to WNV lineage 2. Phylogeographic analysis revealed Hungary's central role in European WNV dissemination since 2004, with multiple introductions and local diversification across distinct clades. Continuous spatial modelling identified Hungary as a persistent transmission hub with bidirectional viral flow to neighbouring countries, contributing to northward expansion. CONCLUSION: Hungary remains a critical WNV transmission hub in Central Europe with established endemicity of multiple lineage 2 clades. The analysis highlights Hungary's role as both a recipient and major source of European WNV diversity, emphasising the need for coordinated surveillance and climate-adapted preparedness strategies.


  • Open Access

    Human Hantavirus Infections in Hungary (2018–2025): Epidemiology, Molecular Detection Across Clinical Sample Types, and Phylogenetic Analysis

    by Anita Koroknai, Anna Nagy, Orsolya Nagy, Nikolett Csonka, Levente Zsichla, Katalin Szomor, Mária Takács

    Hantaviruses are globally distributed, rodent-borne zoonotic pathogens. In Hungary, Dobrava-Belgrade virus (DOBV) and Puumala virus (PUUV) are circulating, causing hemorrhagic fever with renal syndrome and nephropathia epidemica, respectively. Due to the short viremic period, hantaviruses are primarily diagnosed by serological methods. Detection of viral nucleic acid by real-time or nested reverse transcription polymerase chain reaction (RT-PCR) is limited to samples collected in the early phase of disease. Between 2018 and 2025, 51 laboratory-confirmed hantavirus infections were identified in Hungary; 30 cases were assigned to DOBV, 20 to PUUV, and one remained undetermined. Most patients were male (82%), suggesting increased exposure-related risk. Viral RNA was detected in 21 cases, mainly from serum and whole blood samples, and sporadically from urine. In three DOBV cases, viral RNA was detectable exclusively in whole blood but not in paired serum samples. Phylogenetic analysis included four PUUV and six DOBV partial S segment sequences showing high similarity to other human- and rodent-derived samples from the region. Hantavirus infections remain infrequently diagnosed in Hungary. Our findings suggest that serum and whole blood may be useful specimen types for molecular detection, whereas urine had limited diagnostic value in our dataset.


  • Open Access

    Lymphocytic Choriomeningitis Virus Infections in Hungary between 2017–2023—Investigation of the First Congenital Infections

    by Anita Koroknai, Anna Nagy, Orsolya Nagy, Nikolett Csonka, Eszter Mezei, Katalin Szomor, Mária Takács

    Lymphocytic choriomeningitis virus (LCMV) is a neglected rodent-borne arenavirus, primarily spread by common house mouse species. Acquired human infections range from asymptomatic to mild flu-like symptoms and self-resolving neurological diseases. In contrast, intrauterine LCMV infection is associated with high mortality and morbidity. Infection of the fetus often leads to fetal death, and surviving fetuses may develop vision impairment and central nervous system developmental disorders. LCMV is mainly diagnosed by serological methods using in-house indirect immunofluorescence assays. LCMV nucleic acid is detected by the nested RT-PCR method and confirmed by Sanger sequencing. In Hungary, 23 acquired lymphocytic choriomeningitis cases were diagnosed between 2017 and 2023. Ten out of 23 confirmed patients proved to be positive by the PCR method. Two cases of intrauterine LCMV infections were detected in 2019 and 2021, respectively. The IgG antibody titers measured in the infant’s serum samples were much higher than the IgG titers of the maternal serum samples. Both IgM and IgA antibodies were detectable in the infants’ sera. As the microbiological diagnosis of LCMV is rather challenging and the symptoms are very similar to the clinical picture of other common teratogenic pathogens such as cytomegalovirus or Toxoplasma gondii, intrauterine LCMV infections might still be underdiagnosed.